Inventor · disambiguated record
Phillip Kim
Also filed as: KIM PHILLIP · KIM PHILLIP S
19 granted patents·12 pending applications·126 citations·filing 1996–2024
93Inventor score
Top patents by PatentIndex Score
31 records- 0197US8163499B2Drug selection for breast cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2009·Granted Apr 24, 2012·53 cites·88 claims
- 0294US8609349B2Drug selection for breast cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2012·Granted Dec 17, 2013·12 cites·42 claims
- 0391US9285369B2Antibody-based arrays for detecting multiple signal transducers in rare circulating cellsNESTEC SA·Filed 2014·Granted Mar 15, 2016·7 cites·20 claims
- 0491US9274116B2Drug selection for breast cancer therapy using antibody-based arraysNESTEC SA·Filed 2013·Granted Mar 1, 2016·7 cites·48 claims
- 0588US9575066B2Antibody-based arrays for detecting multiple signal transducers in rare circulating cellsNESTEC SA·Filed 2013·Granted Feb 21, 2017·5 cites·15 claims
- 0687US10697967B2Methods for predicting response of triple-negative breast cancer to therapyNESTLE SA·Filed 2016·Granted Jun 30, 2020·4 cites·16 claims
- 0787US8658388B2Antibody-based arrays for detecting multiple signal transducers in rate circulating cellsHARVEY JEANNE·Filed 2008·Granted Feb 25, 2014·14 cites·27 claims
- 0881US9719995B2Drug selection for colorectal cancer therapy using receptor tyrosine kinase profilingNESTEC SA·Filed 2013·Granted Aug 1, 2017·3 cites·17 claims
- 0979US10436786B2Methods for detecting truncated receptors using antibody-based arraysNESTLE SA·Filed 2016·Granted Oct 8, 2019·1 cites·20 claims
- 1079US9664683B2Profiling of signal pathway proteins to determine therapeutic efficacyNESTEC SA·Filed 2014·Granted May 30, 2017·3 cites·27 claims
- 1166US10527622B2Antibody-based arrays for detecting multiple signal transducers in rare circulating cellsNESTLE SA·Filed 2017·Granted Jan 7, 2020·0 cites·18 claims
- 1262US11779464B2Customized ventricular support deviceUNIV WAKE FOREST HEALTH SCIENCES·Filed 2018·Granted Oct 10, 2023·1 cites·34 claims
- 1362US10401364B2Drug selection for colorectal cancer therapy using receptor tyrosine kinase profilingNESTEC SA·Filed 2017·Granted Sep 3, 2019·0 cites·10 claims
- 1462US2024262879A1IL-12 Fc FUSION PROTEINSBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1561US2024417437A1Linker PolypeptidesTRUTINO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1660US9726669B2Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapyKIM PHILLIP·Filed 2010·Granted Aug 8, 2017·1 cites·53 claims
- 1751US2014099300A1Methods for predicting and improving the survival of gastric cancer patientsNESTEC SA·Filed 2013·Application pending·0 cites
- 1850US9903867B2Methods for predicting and improving the survival of colorectal cancer patientsNESTEC SA·Filed 2015·Granted Feb 27, 2018·0 cites·7 claims
- 1949US2008311568A1Compositions and Methods for Nucleic Acid Analysis of Sequences with Insertions or DeletionsAUTOGENOMICS INC·Filed 2005·Application pending·0 cites
- 2047US2017285044A1Methods for predicting and improving the survival of gastric cancer patientsPIERIAN HOLDINGS INC·Filed 2017·Application pending·0 cites
- 2147US2024043489A1Cytokine Prodrugs Comprising a Cleavable LinkerTRUTINO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2245US9488654B2Methods for predicting response of triple-negative breast cancer to therapyLIU XINJUN·Filed 2012·Granted Nov 8, 2016·0 cites·3 claims
- 2345US2022267400A1Il-2 cytokine prodrugs comprising a cleavable linkerTRUTINO BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2442US2014273006A1Method of therapy selection for patients with cancerNESTEC SA·Filed 2014·Application pending·0 cites
- 2542US2012270745A1Drug selection for cancer therapy by profiling signal transduction proteins in ascites or pleural efflux samplesSINGH SHARAT·Filed 2012·Application pending·0 cites
- 2640US10640830B2Drug selection for non-small cell lung cancer therapyNESTEC SA·Filed 2015·Granted May 5, 2020·0 cites·19 claims
- 2740US10473640B2Drug selection for gastric cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2011·Granted Nov 12, 2019·0 cites·18 claims
- 2840US5850947AInvertible and multi-directional fluid delivery deviceFiled 1996·Granted Dec 22, 1998·15 cites·6 claims
- 2940US2012231965A1Drug selection for colorectal cancer therapy using antibody-based arraysKIM PHILLIP·Filed 2012·Application pending·0 cites
- 3038US2016025730A1Methods of selecting combination therapy for colorectal cancer patientsNESTEC SA·Filed 2015·Application pending·0 cites
- 3137US2019219580A1Methods of drug therapy selection for breast cancer patients based on her2 and her3 pathway subtypingNESTEC SA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phillip Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →